Envista Holdings (NVST) Exchange Rate Effect (2019 - 2026)
Envista Holdings (NVST) recorded quarterly Exchange Rate Effect of -$11.1 million in Q2 2026, down 205.71% quarter-over-quarter from $10.5 million in Q4 2025, and down 132.36% on a YoY basis from $34.3 million in Q2 2025.
Envista Holdings (NVST) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Envista Holdings' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$11.1 million for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 132.36% year-over-year to -$11.1 million; the TTM figure through Apr 2026 stood at $43.5 million (up 1075.68% YoY), while the FY2025 annual figure was $88.9 million, up 281.06% from the prior year.
- Exchange Rate Effect was -$11.1 million for Q2 2026 at Envista Holdings, down from $10.5 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $48.1 million in Q2 2025 to a low of -$46.3 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged $1.5 million across 5 years, with a median of -$2.5 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect plunged 1323.08% in 2024, then surged 23950.0% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at -$2.5 million in 2022, then soared by 1024.0% to $23.1 million in 2023, then tumbled by 300.43% to -$46.3 million in 2024, then jumped by 122.68% to $10.5 million in 2025, then sank by 205.71% to -$11.1 million in 2026.
- The last three Exchange Rate Effect figures came in at -$11.1 million (Q2 2026), $10.5 million (Q4 2025), and -$4.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -7.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 2.58 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -8.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -2.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -3.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -6.39 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -18.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | -11.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -11.10 Mn |
| Apr 3, 2026 | -11.10 Mn |
| Dec 31, 2025 | 10.50 Mn |
| Dec 31, 2025 | 10.50 Mn |
| Sep 26, 2025 | -4.00 Mn |
| Sep 26, 2025 | -4.00 Mn |
| Jun 27, 2025 | 48.10 Mn |
| Jun 27, 2025 | 48.10 Mn |
| Mar 28, 2025 | 34.30 Mn |
| Mar 28, 2025 | 34.30 Mn |
| Dec 31, 2024 | -46.30 Mn |
| Dec 31, 2024 | -46.30 Mn |
| Sep 27, 2024 | 15.50 Mn |
| Sep 27, 2024 | 15.50 Mn |
| Jun 28, 2024 | 200,000.00 |
| Jun 28, 2024 | 200,000.00 |
| Mar 29, 2024 | -18.50 Mn |
| Mar 29, 2024 | -18.50 Mn |
| Dec 31, 2023 | 23.10 Mn |
| Dec 31, 2023 | 23.10 Mn |